Retatrutide in Canada: legal status and what to know
Updated October 29, 2026. Based on Health Canada's public advisory (April 9, 2026), cited below. Not legal or medical advice.
Health Canada's April 2026 advisory names retatrutide among examples of unauthorized injectable peptide drugs.
- It is a drug that has been in clinical trials.
What the regulator says
- Injectable peptides for human use are regulated as prescription drugs and must be authorized before sale.
- Retatrutide is on the advisory's list of examples, alongside BPC-157, TB-500, GHK-Cu, CJC-1295 and others.
- A "For Research Use Only" label does not make a product legal, per Health Canada.
How to check any drug yourself
| Step | What to do |
|---|---|
| 1 | Look for an eight-digit DIN on the label of any prescription drug |
| 2 | Search the name in Health Canada's Drug Product Database |
| 3 | Ask a pharmacist or doctor about anything meant for your own use |
More context: retatrutide phase 3 results (company reported), the advisory explained and are peptides legal in Canada.
Ready to order?
Enter the code at checkout. If you copied it, just paste it in the Promo code box in the order summary, then press Apply. It does not apply by itself. Confirm the discount line before you pay.
Common questions
Is retatrutide legal in Canada?
Health Canada's April 2026 advisory lists it among unauthorized injectable peptide drugs.
Is retatrutide approved anywhere?
It is in clinical trials. Check the regulator for the latest status.
How can I tell if a drug is authorized?
Look for an eight-digit DIN and search the Drug Product Database.
Sources
- Health Canada: Think twice before injecting peptides bought online (public advisory, Apr 9, 2026)
- AJMC: Retatrutide phase 3 TRIUMPH-1 results (May 21, 2026)
Summarised in my own words. Read the originals for the full detail.